Member Info for andinio

Since IP Group and Invesco committed to Cathal's plan much has changed. Funds will buy and sell to their own agenda.
Whichever of the funds are selling and to what extent is immaterial to the success of the plan.
Anyone holding Orph shares during the recent downturn has been protected thus far from major reductions in value experienced across the market.
Delivery of the plan is all that matters. Right now, at this time, we're further forward than we could have hoped for three/four weeks ago.

You couldn't ask anymore from Cathal.
He's doing everything you'd want and desire from Executive Chairman, broker and CEO combined.

I took a nibble this morning based on the RNS.
Will slice in some more if IMMO takes on more water.
Future: rather visit Sea park and take in a virtual experience than take a cruise :)

Blahblahdoh
So much has happened, i forgot. You're right, that was the key element for me, also.
Maurice Treacy is still working on the database which includes using data from hVIVO (yet another bonus from the reverse takeover). It rarely gets a mention now from Cathal. He did make it clear in a recent webinar that the data platform is as relevant as it ever was but there's just so much to talk about.
That statment alone is reassuring and one we all know to be true.

Interesting times, deepjoy. Interesting times.

Cathal even commented about possibility of buying out the legacy holders who are dumping into price rise.
I wouldn't bank on that but it does demonstrate - if we needed further demonstration - that Cathal is proactive in all aspects of the business.
He's firmly strapped into the driving seat. Reassuring stuff, this week.

Four weeks ago i was confident to invest in 500k + shares
Today, i'm more confident than ever.
Business working to profitability as pharmaceutical services + virology and vaccine challenge study provider
.. plus coronavirus challenge study development
.. plus compelling reasons to be optimistic of Flu V licensing or asset sale

Yes, it is a disaster.
Trump's completely obsessed with numbers and spats.

You have to grant Cathal and the team 10/10 for delivery. The business model was to become profitable this year and exit late 2020 with a share multiplier of 2 to 3 times. This plan was prepared before coronavirus took hold in China.
There is no doubt in my mind that we are very much on-track with the plan.

During the recent stock market storms (plural) Orph has proven to be a safe house for investors.
Excuse me if I don't take any investor lessons from forum comments attempting to knock Open Orphan.

We (in UK) have the very best experts. Let's get to work.

Hi Woodie.
Perhaps it's time for everyone to eat less :)

Times Article:
"Once Hvivo has secured permission from the UK’s Medicines and Healthcare products Regulatory Agency, testing will begin. Up to 24 volunteers at a time will be kept in quarantine at Hvivo’s laboratory at Queen Mary BioEnterprises Innovation Centre at Whitechapel in east London. They will be infected with two common strains of coronavirus, 0C43 and 229E, from the same family of viruses, but which cause only a mild respiratory illness. It will allow researchers and pharmaceuticals firms to test the efficacy of new viruses and antiviral medications in a safe environment."

Times article:
"It makes the involvement of British companies such as Hvivo important. Its plan, to test a less harmful virus that is closely related to Covid-19, has caught the attention of Chinese pharmaceuticals firms, who have agreed to co-fund the study. Cathal Friel, executive chairman of Hvivo’s parent company, Open Orphan, said it placed the company at the “forefront of the fight against the outbreak”.

Leave Ammu alone.
I've enjoyed his comments, especially the one about Orph needing a placing 'right about now'.
It's rare to witness an incoherrent monkey outside of his natural wild habitat.
Priceless.

Bronxville.
Agreed, timing of deal-making and fund raise ref Orph cannot be understated.

Cathal talks about new contract:
https://www.###markets.co.uk/media/5e624ec2052336001724ec8e/?context=/series/daily-podcast/
note: replace xxx with v o x

I know. I had to remind myself only yesterday :)
Too much information to recall.

Invesco (not Investec)
Significant shareholder info after Jupiter TR1 share sale.
https://www.openorphan.com/investors/significant-shareholder-information

MMs made plenty of money on today's news.